IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2001 by National Cancer Institute (NCI).
Recruitment status was: Active, not recruiting
Recruitment status was: Active, not recruiting
Sponsor:
Theradex
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00003326
First received: November 1, 1999
Last updated: July 23, 2008
Last verified: April 2001
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Study Completion Date: | No date given |
| Primary Completion Date: | No date given |